- Docket No.
- 1:25-cv-3452
- District Court
- Colorado
Goal
- Block enforcement of a law
- Declaration that a law is unlawful
Issues
Litigation Content
Why this Matters:
The plaintiffs argue that the Colorado Prescription Drug Affordability Board’s setting of the upper payment limit for brand-named prescription drugs dispensed within Colorado is preempted by federal patent laws, violates the Due Process Clause, and impermissibly regulates out-of-state transactions. Prescription Drug Affordability Boards are one approach states are currently pursuing to lower prescription drug costs for their residents.
Potential Impact:
Successful challenges to state measures addressing prescription drug affordability could negate savings for patients and impede state efforts to curb the high cost of prescription drugs.